Pacific Biosciences (Cornell) Announces Pricing of Initial Public Offering of Common Stock (10/26/2010)

Pacific Biosciences, a spinoff from the Cornell Nanobiotechnology Center, has developed a novel approach to studying the synthesis and regulation of DNA, RNA and proteins.

Pacific Biosciences of California, Inc. (NASDAQ: PACB), developer of single molecule, real-time (SMRT™) technology for biological analysis, announced today the pricing of its initial public offering of 12,500,000 shares of its common stock at $16.00 per share. All shares are being sold by the company. The Company is also offering its underwriters a 30-day option to purchase up to 1,875,000 shares at the initial public offering price to cover overallotments, if any. The shares are expected to begin trading on Wednesday, October 27, 2010 on the NASDAQ Global Select Market under the ticker symbol “PACB”. read more

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: